Abstract
Background and objectivesGenetic variants inNAT8, a liver- and kidney-specific acetyltransferase encoding gene, have been associated with eGFR and CKD in European populations. Higher circulating levels of twoNAT8-associated metabolites, N-δ-acetylornithine and N-acetyl-1-methylhistidine, have been linked to lower eGFR and higher risk of incident CKD in the Black population. We aimed to expand upon prior studies to investigate associations between rs13538, a missense variant inNAT8, N-acetylated amino acids, and kidney failure in multiple, well-characterized cohorts.Design, setting, participants, & measurementsWe conducted analyses among participants with genetic and/or serum metabolomic data in the African American Study of Kidney Disease and Hypertension (AASK;n=962), the Atherosclerosis Risk in Communities (ARIC) study (n=1050), and BioMe, an electronic health record–linked biorepository (n=680). Separately, we evaluated associations between rs13538, urinary N-acetylated amino acids, and kidney failure in participants in the German CKD (GCKD) study (n=1624).ResultsOf 31 N-acetylated amino acids evaluated, the circulating and urinary levels of 14 were associated with rs13538 (P<0.05/31). Higher circulating levels of five of these N-acetylated amino acids, namely, N-δ-acetylornithine, N-acetyl-1-methylhistidine, N-acetyl-3-methylhistidine, N-acetylhistidine, and N2,N5-diacetylornithine, were associated with kidney failure, after adjustment for confounders and combining results in meta-analysis (combined hazard ratios per two-fold higher amino acid levels: 1.48, 1.44, 1.21, 1.65, and 1.41, respectively; 95% confidence intervals: 1.21 to 1.81, 1.22 to 1.70, 1.08 to 1.37, 1.29 to 2.10, and 1.17 to 1.71, respectively; allPvalues <0.05/14). None of the urinary levels of these N-acetylated amino acids were associated with kidney failure in the GCKD study.ConclusionsWe demonstrate significant associations between anNAT8gene variant and 14 N-acetylated amino acids, five of which had circulation levels that were associated with kidney failure.
Funder
National Institute of Diabetes and Digestive and Kidney Diseases
Deutsche Forschungsgemeinschaft
National Heart, Lung, and Blood Institute
National Institutes of Health
US Department of Health and Human Services
National Human Genome Research Institute
JLH Foundation
Bundesministerium für Bildung und Forschung
KfH-Stiftung Präventivmedizin
Publisher
American Society of Nephrology (ASN)
Subject
Transplantation,Nephrology,Critical Care and Intensive Care Medicine,Epidemiology